PhageBase: A visual atlas of phages

Issue 280 | September 6, 2024
9 min read
Capsid and Tail

This week Aaryan Harshith, sophomore student at Stanford (and one of Jess’ new labmates!) shares how and why he built a hand-curated database of phage TEM images. Check it out and add yours!

Sponsor

Podovirus Podcast banner

Why isn’t phage therapy a thing yet? What’s taking so long?

I’m super excited to share our new podcast, Podovirus. This is a new experiment. I wanted a (better?) excuse to have in-depth conversations with some of my favorite phage people, and ask them about what they’re doing, what work still needs to be done, why certain things are hard, etc.

Come join the fun!

🎙️ Most recent episode: Getting phage research funded — Former NIH program officer Joe Campbell reflects on his career watching & helping phage work get funded

🎧 Listen: Podovirus on Spotify

🎥 Watch: Podovirus on YouTube

Subscribe to get the next episodes!

✂️ Up next: Jesus Fernandez (Eligo Bioscience’s VP Technology) on Eligo’s new microbiome editing tech & how it works

🩺 On deck: Joe Campbell will join as a co-host as we interview Dr. Gina Suh about phage therapy bottlenecks she’s facing as a clinician

What’s New

Nicholas Smith (University at Buffalo) and Dwayne Roach (San Diego State University) received a $3.6 million NIH grant to study pharmacokinetics and pharmacodynamics of mechanistically aware phage cocktails.

Funding newsGrant fundingPhage pharmacokinetics

Associate Professor Jeremy Barr (Monash University) received $500,000 USD from the Bill & Melinda Gates Foundation to investigate how phages interact with the human immune system and their potential implications for treating inflammatory diseases.

Funding newsPhage immune interactions

Phage protein moonlighting alert! Abdulrazak Alsaleh (Liverpool John Moores University) and colleagues published a new paper on how large serine integrases utilize scavenged phage proteins to control the directionality of integration.

IntegrasesPreprintMoonlighting

Amit Rimon (Hebrew University of Jerusalem) and colleagues published a new paper on combinatorial treatment of pulsed blue light and phage therapy for antibiotic-resistant P. aeruginosa, showing a synergistic bactericidal effect on planktonic cultures and formed biofilms.

Research paperBiofilmsLight therapy

Matt McEnany (U Colorado) and Kevin Outterson (Boston University, Founder and Executive Director of CARB-X) published a new paper on evaluating Germany’s new antimicrobial reimbursement reforms. They compare these reforms to delinked pull incentives (where governments pay drug companies after they make their drug, independently of how much their drug is sold).

Antimicrobial resistancePull incentivesDrug development

Latest Jobs

Phage therapymicrobiologyInternship
Tolka AI Therapeutics (now backed by Khosla Ventures!) is a biotech startup in Miami, Florida focused on developing phage therapy for M. abscessus infections. Tolka is hiring a Microbiology Intern to assist in phage hunting and developing treatments for antibiotic-resistant infections.
Phage-host interactionsPhD project
Humboldt University Berlin (Germany) is hiring a PhD position to investigate immune mechanisms of bacteria against phages using live-cell microscopy and bacterial genetics.

Community Board

Anyone can post a message to the phage community — and it could be anything from collaboration requests, post-doc searches, sequencing help — just ask!

ISVM members are invited to participate in the upcoming elections for the ISVM Executive Board, with candidate applications due by September 27th, 2024, and voting taking place from October 7th to 21st, 2024, to shape the future of the organization and its initiatives in viruses of microbes research.

ElectionsISVMScientific society

PhageBase: A visual atlas of phages

Profile Image
Research Assistant
Skills

Phage isolation, Microbiology, propagation of phages, characterization of phages

Currently bioprospecting for new phages that target multi drug-resistant Pseudomonas bacteria.

Dear Phage community,

Since this is my first post to the community, I thought I’d introduce myself.

Hi, I’m Aaryan! Right now, I’m working with the Bollyky Lab at Stanford University, specifically on phages to target resistant strains of P. aeruginosa. Beyond that, I love building tools to support the phage community.

In this article, I’m announcing the launch of PhageBase (www.phagebase.com) — the world’s largest atlas of bacteriophage images.

But before I explore how PhageBase can accelerate and promote your research, let’s think about why this matters at all.

How It Began

PhageBase was born from an interaction I had with my former mentor, Arne Echterhof. At the time, Arne just received a new phage called Terra from one of our collaborators. All he wanted was to find its dimensions so he could embed it in a hydrogel with the right pore size. But it took him nearly a week of tortured searching to find what he was looking for.

Why did Arne have to spend so much time away from his research scouring the internet for public data? Why wasn’t such basic information about phages available in one place?

Later that weekend, I put together a janky HTML site called PhageBase to host data on our lab’s most common phages. Soon enough, though, we realized our lab wasn’t the only group using the platform. So we continued to polish the site, expand our dataset, and iterate on feedback. And now we’re here.

The user interface for PhageBase

The user interface for PhageBase

Where We’re At

To our knowledge, PhageBase is now the largest repository of its kind, with structural and micrographic data on over 1000 phages spanning 150+ bacterial hosts. Here’s how you can use it to accelerate your research:

Exploring Phages

PhageBase helps you find phages faster than Google Scholar. And since the platform focuses exclusively on phages, it lets you filter by name, host, and morphology.

The “Filter” and “Sort” tools are available at the top left of the database window

The “Filter” and “Sort” tools are available at the top left of the database window

Example: To find all the podophages that infect V. cholera, just set the “Host” to V. Cholera and the “Morphotype” property to podovirus. Each entry contains a detailed register of information about the phage, all of which were inputted and cross-checked by human reviewers. To learn more, just click the link in the “Attribution” section to read the paper where the phage was originally described.

In short, PhageBase lets you find data on virtually any phage instantly. That means less time scouring obscure papers for tidbits of data. Which leaves more time to run your experiments, get published, and test out new ideas.

Contributing Phages

PhageBase was designed to be an open exchange. We want it to grow into a thriving community, where people can learn with and from each other.

Example: If your lab just isolated a new phage, use our Contribute Data form to make it visible to researchers around the world. If your lab just published a paper, use the same form to spread the word and get more citations. Aside from advancing your career, this is a simple practice to give back to the phage community.

PhageBase is open to contributions from the community!

Finding Collaborators

From speaking with our fellow researchers, we noticed that it was still tough for our community to connect. We wanted to change that.

Example: Did you have a question about one of the papers on PhageBase? Or, are you trying to buy a phage that just isn’t available online? What if you just want to have a conversation with a research group halfway across the world? Just open up the paper listed on PhageBase and email the corresponding author.

Example of PhageBase interface alongside source research paper

Next Steps

Of course, these features represent a fraction of what PhageBase could be. We’re still adding phages to our repository and brewing up new ideas every day.

By the end of the year, we want PhageBase to reach its first 10,000 phages. We also want to grow the list of parameters offered for our entries (i.e. burst size, genome length, etc.) and extend the platform into an API. And, of course, we want to launch systems that make it easier for our community to collaborate and build on each other’s work. In other words, there’s a lot left for this platform to give.

Where We’re Headed

At one point, for personal computing to mature, we had to transition from clunky, home-built transistors, to precision-engineered chips fabricated on assembly lines. For synthetic biology to mature, we first had to systemize the art of gene expression, sequencing, and purification.

History shows us that most of our globally relevant technologies began in the labs and garages of a handful of passionate tinkerers. But for these tools to develop from pet projects into industries, all of them first had to be organized and developed. Standards had to be set. Infrastructure had to be built. Data had to be centralized.

In the grand scheme of phage therapy, we find ourselves at this exact turning point. And as the founding tinkerers of this field, we get the chance to write the rules that define its future.

How You Can Get Involved

We want PhageBase to become a hub that enables this future. If our mission resonates with you, there are three main ways you can join our journey.

  1. We need more people talking about PhageBase. If you share PhageBase on X and The Phage Directory (and send me screenshots of both at [email protected]), you’ll get a chance to win one of three T4-phage plushies.

  2. We’re putting together an informal board of directors to steer PhageBase over the long term. If you either run a phage lab, help lead people at a phage startup, or know someone who fits this description and might be interested, email me at [email protected].

  3. Right now, we’re getting more phage contributions than we can review on our own. If you’re interested in volunteering with us and gaining meaningful experience with phage research…again, email me! (While we think this opportunity is probably most valuable to high-schoolers and university students, we welcome anyone who cares about phage research).

Of course, I’m also curious to hear what you think about the platform. What are your initial reactions? Where do you think we can improve?

Time after time, this community has surprised me with its drive and generosity. I find myself counting on you again. Let’s rely on each other to advance our research. Let’s make order from the chaos that surrounds us. Together, let’s make phage research as exciting and promising as we all know it can be.

Capsid & Tail

Follow Capsid & Tail, the periodical that reports the latest news from the phage therapy and research community.

We send Phage Alerts to the community when doctors require phages to treat their patient’s infections. If you need phages, please email us.

Sign up for Phage Alerts

In collaboration with

Mary Ann Liebert PHAGE

Supported by

Leona M. and Harry B. Helmsley Charitable Trust

Crossref Member Badge